Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Anemia
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Recruiting
Phase:
N/A
Intervention Type:
Other
Participants:
20
Start Date:
April 20, 2022
Umbilical Cord Blood Treatment for Refractory Immune Cytopenia: a Single-arm Prospective Study
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Dietary Supplement
Participants:
140
Start Date:
January 2022
To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in Pregnancy
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Other
Participants:
10
Start Date:
August 1, 2021
Fitness Intervention Trial in Adults With Sickle Cell Disease (SCD Fit): A Feasibility Study
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Dietary Supplement, Drug
Participants:
100
Start Date:
July 2021
Management of Severe Acute Malnutrition in Children With Sickle Cell Disease Greater Than 5 Years of Age Living in Northern Nigeria
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
22
Start Date:
June 30, 2021
A Phase 2 Trial of Acalabrutinib for the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
167
Start Date:
June 3, 2021
An Open Label, Multicenter Roll-over Extension Program (REP) to Characterize the Long-term Safety and Tolerability of Iptacopan (LNP023) in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Completed PNH Phase 2 and Phase3 Studies With Iptacopan
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
240
Start Date:
June 2021
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subjects With Transfusion-Dependent Alpha- or Beta-Thalassemia (ENERGIZE-T)
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
171
Start Date:
June 2021
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subjects With Non-Transfusion Dependent Alpha- or Beta-Thalassemia (ENERGIZE)
Clinical Trial
Status:
Not yet recruiting
Intervention Type:
Diagnostic Test
Participants:
100
Start Date:
June 1, 2021
Thrombophilia Versus Platelet Dysfunction In Beta Thalassemia
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Drug
Participants:
9
Start Date:
May 28, 2021
Transplantation of CRISPRCas9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Other, Procedure
Participants:
140
Start Date:
May 2021
Thoracic Kyphosis and Osteoporosis: Study of Their Relationship With Respiratory Functions in Chronic Obstructive Pulmonary Disease.
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Drug
Participants:
23
Start Date:
May 2021
A Multicenter, Open-label, Non-randomized, Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia
Showing 1-12 of 824
Next